Merck to Acquire Cidara Therapeutics for $9.2 Billion, Gaining Phase 3 Antiviral Candidate CD388
Market Chameleon (Fri, 14-Nov 10:29 AM)
Merck’s $9.2 Billion Cidara Therapeutics Acquisition Highlights High-Stakes Bet on Universal Flu Prevention
Market Chameleon (Fri, 14-Nov 7:05 AM)
